Statens legemiddelverk — Norwegian Medicines Agency Shortages (NOMA)
Statens legemiddelverk — Norwegian Medicines Agency Shortages is the official source of medicine shortage information for Norway (Europe). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- legemiddelverket.no
- Country
- Norway
- Notices tracked by Mederti
- 1,218
- Last checked
- 2 Aug 2026
Latest notices from NOMA
- Nifedipin — active, medium, since 1 Oct 2026 (source)
- Penciklovir — active, medium, since 1 Oct 2026 (source)
- Lantankarbonathydrat — active, medium, since 15 Sept 2026 (source)
- Østriol — active, medium, since 9 Sept 2026 (source)
- Sumatriptansuksinat — active, medium, since 7 Sept 2026 (source)
- Oksykodonhydroklorid — active, medium, since 7 Sept 2026 (source)
- Gadoksetatdinatrium — active, medium, since 3 Sept 2026 (source)
- Sumatriptansuksinat — active, medium, since 1 Sept 2026 (source)
- Sotalolhydroklorid — active, medium, since 1 Sept 2026 (source)
- Vinflunineditartrat — active, medium, since 1 Sept 2026 (source)
- Pantoprazolnatriumseskvihydrat — active, medium, since 1 Sept 2026 (source)
- Argatrobanmonohydrat — active, medium, since 31 Aug 2026 (source)
- Penciklovir — active, medium, since 31 Aug 2026 (source)
- Olanzapin — active, medium, since 31 Aug 2026 (source)
- Metylfenidathydroklorid — active, medium, since 31 Aug 2026 (source)
Every NOMA notice, searchable and alertable
Search Norway's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by Statens legemiddelverk — Norwegian Medicines Agency Shortages. All notices remain the property of their publisher and are linked to the original source.